Bank of America’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,224
| Closed | -$128K | – | 8397 |
|
|
2025
Q1 | $128K | Sell |
26,224
-27,324
| -51% | -$164K | ﹤0.01% | 6382 |
|
|
2024
Q4 | $447K | Sell |
53,548
-17,039
| -24% | -$149K | ﹤0.01% | 5632 |
|
|
2024
Q3 | $733K | Buy |
70,587
+6,564
| +10% | +$109K | ﹤0.01% | 5255 |
|
|
2024
Q2 | $1.26M | Sell |
64,023
-736
| -1% | -$14.7K | ﹤0.01% | 4752 |
|
|
2024
Q1 | $1.66M | Sell |
64,759
-16,431
| -20% | -$421K | ﹤0.01% | 4575 |
|
|
2023
Q4 | $2.24M | Buy |
81,190
+20,339
| +33% | +$1.24M | ﹤0.01% | 4292 |
|
|
2023
Q3 | $3.7M | Sell |
60,851
-35,879
| -37% | -$2.52M | ﹤0.01% | 3680 |
|
|
2023
Q2 | $6.36M | Sell |
96,730
-1,534
| -2% | -$112K | ﹤0.01% | 3170 |
|
|
2023
Q1 | $6.25M | Buy |
98,264
+63,252
| +181% | +$7.22M | ﹤0.01% | 3314 |
|
|
2022
Q4 | $4.85M | Buy |
35,012
+5,337
| +18% | +$752K | ﹤0.01% | 3414 |
|
|
2022
Q3 | $3.76M | Buy |
29,675
+26,250
| +766% | +$2.97M | ﹤0.01% | 3641 |
|
|
2022
Q2 | $284K | Sell |
3,425
-29,426
| -90% | -$2.28M | ﹤0.01% | 5846 |
|
|
2022
Q1 | $3.19M | Sell |
32,851
-1,895
| -5% | -$250K | ﹤0.01% | 4105 |
|
|
2021
Q4 | $6.94M | Buy |
34,746
+26,000
| +297% | +$6.14M | ﹤0.01% | 3322 |
|
|
2021
Q3 | $2.17M | Sell |
8,746
-5,388
| -38% | -$1.54M | ﹤0.01% | 4373 |
|
|
2021
Q2 | $5.86M | Sell |
14,134
-6,666
| -32% | -$2.64M | ﹤0.01% | 3376 |
|
|
2021
Q1 | $8.12M | Sell |
20,800
-2,343
| -10% | -$1.15M | ﹤0.01% | 2923 |
|
|
2020
Q4 | $13M | Sell |
23,143
-10,302
| -31% | -$6.53M | ﹤0.01% | 2270 |
|
|
2020
Q3 | $23.4M | Buy |
33,445
+2,044
| +7% | +$1.59M | ﹤0.01% | 1581 |
|
|
2020
Q2 | $24.8M | Buy |
31,401
+9,691
| +45% | +$7.31M | ﹤0.01% | 1464 |
|
|
2020
Q1 | $12.9M | Buy |
21,710
+8,019
| +59% | +$7.81M | ﹤0.01% | 1844 |
|
|
2019
Q4 | $15.6M | Sell |
13,691
-6,685
| -33% | -$7.27M | ﹤0.01% | 2124 |
|
|
2019
Q3 | $24.2M | Sell |
20,376
-18,631
| -48% | -$28.5M | ﹤0.01% | 1674 |
|
|
2019
Q2 | $64.3M | Sell |
39,007
-21,458
| -35% | -$37.1M | 0.01% | 969 |
|
|
2019
Q1 | $123M | Buy |
60,465
+28,645
| +90% | +$50.4M | 0.02% | 654 |
|
|
2018
Q4 | $40.9M | Buy |
31,820
+17,156
| +117% | +$26.3M | 0.01% | 1137 |
|
|
2018
Q3 | $27.7M | Buy |
14,664
+2,629
| +22% | +$5.43M | ﹤0.01% | 1564 |
|
|
2018
Q2 | $24.5M | Buy |
12,035
+2,527
| +27% | +$5.76M | ﹤0.01% | 1639 |
|
|
2018
Q1 | $21M | Buy |
9,508
+113
| +1% | +$287K | ﹤0.01% | 1728 |
|
|
2017
Q4 | $21.7M | Sell |
9,395
-1,015
| -10% | -$2.06M | ﹤0.01% | 1736 |
|
|
2017
Q3 | $18.5M | Buy |
10,410
+3,894
| +60% | +$5.44M | ﹤0.01% | 1942 |
|
|
2017
Q2 | $8.87M | Buy |
6,516
+891
| +16% | +$1.08M | ﹤0.01% | 2488 |
|
|
2017
Q1 | $6.62M | Sell |
5,625
-4,783
| -46% | -$4.88M | ﹤0.01% | 2769 |
|
|
2016
Q4 | $8.32M | Buy |
10,408
+809
| +8% | +$642K | ﹤0.01% | 2472 |
|
|
2016
Q3 | $8.43M | Sell |
9,599
-445
| -4% | -$322K | ﹤0.01% | 2387 |
|
|
2016
Q2 | $5.63M | Sell |
10,044
-2,136
| -18% | -$1.21M | ﹤0.01% | 2712 |
|
|
2016
Q1 | $6.71M | Sell |
12,180
-1,351
| -10% | -$830K | ﹤0.01% | 2514 |
|
|
2015
Q4 | $11.3M | Buy |
13,531
+4,863
| +56% | +$4.86M | ﹤0.01% | 2161 |
|
|
2015
Q3 | $9.61M | Buy |
8,668
+2,381
| +38% | +$4.34M | ﹤0.01% | 2256 |
|
|
2015
Q2 | $13.7M | Buy |
6,287
+2,780
| +79% | +$5.66M | ﹤0.01% | 1683 |
|
|
2015
Q1 | $5.49M | Buy |
3,507
+325
| +10% | +$429K | ﹤0.01% | 2402 |
|
|
2014
Q4 | $3.78M | Sell |
3,182
-760
| -19% | -$508K | ﹤0.01% | 2809 |
|
|
2014
Q3 | $1.83M | Buy |
3,942
+56
| +1% | +$25.8K | ﹤0.01% | 3465 |
|
|
2014
Q2 | $1.94M | Sell |
3,886
-1,706
| -31% | -$547K | ﹤0.01% | 3403 |
|
|
2014
Q1 | $1.65M | Buy |
5,592
+3,745
| +203% | +$1.13M | ﹤0.01% | 3396 |
|
|
2013
Q4 | $501K | Sell |
1,847
-849
| -31% | -$237K | ﹤0.01% | 4765 |
|
|
2013
Q3 | $941K | Buy |
+2,696
| New | +$1M | ﹤0.01% | 4003 |
|
Other funds holding BLUE
Bank of America's BLUE Position: Q2 2025 in Review
Bank of America sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 26,224 shares — an estimated $128K sold.
Bank of America first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $123M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Bank of America reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 26,224 bluebird bio shares in Q2 2025, an estimated $128K.
- Bank of America first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Bank of America's bluebird bio position peaked at $123M in Q1 2019.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.